Market closed

Zoetis/$ZTS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Zoetis

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Ticker

$ZTS

Trading on

NYSE

Industry

Pharmaceuticals

Employees

13,800

Zoetis Metrics

BasicAdvanced
$73B
29.82
$5.47
0.94
$1.80
1.23%
$73B
0.94
$194.42
$144.80
3.1M
$1.80
1.754
0.968
113.774
143.166
31.62%
15.11%
14.90%
51.14%
29.819
8.004
15.34
79.6
32.239
1.10%
1.23%
8.33%
7.89%
5.98%
8.61%
20.00%

What the Analysts think about Zoetis

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Zoetis stock.

Zoetis Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Zoetis Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ZTS

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Apr21
Zoetis
Dividend·Ex-dividend
Jun3
Zoetis
Dividend·Payment
$0.50
Per share
FAQs

What’s the current market cap for Zoetis stock?

Zoetis (ZTS) has a market cap of $73B as of March 31, 2025.

What is the P/E ratio for Zoetis stock?

The price to earnings (P/E) ratio for Zoetis (ZTS) stock is 29.82 as of March 31, 2025.

Does Zoetis stock pay dividends?

Yes, the Zoetis (ZTS) stock pays dividends to shareholders. As of March 31, 2025, the dividend rate is $1.796 and the yield is 1.23%. Zoetis has a payout ratio of 31.62% on a trailing twelve-month basis.

When is the next Zoetis dividend payment date?

The next Zoetis (ZTS) dividend payment is scheduled for June 03, 2025.

What is the beta indicator for Zoetis?

Zoetis (ZTS) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.